Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,029 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

40,029 Papers indexed
1,440 Papers AI scored
40,029 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40029 results
C
Existing 'In-Between': A Qualitative Exploration of Individual, Interpersonal and Structural Influences on Empowerment Among Young Adults With Chronic Health Conditions.
PMID 42895994 Published: 2026-10-01 Ingested: 2026-10-21 09:15 AM Health expectations : an international journal of public participation in health care and health policy
AI -
Standard 57.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 57.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
Burden of dermatology outpatient and inpatient services in China, 2011-2023.
PMID 42890136 Published: 2026-10-02 Ingested: 2026-10-19 09:15 AM Frontiers in public health
AI -
Standard 57.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 57.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
[Desmoplastic infantile gangliogliomas/astrocytomas: clinical course, surgery and morphological diagnosis].
PMID 42885129 Published: 2026-01-01 Ingested: 2026-10-18 09:15 AM Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko
AI -
Standard 57.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 57.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
Clinical and Genetic Characterization of Russian Patients with von Hippel-Lindau Syndrome.
PMID 42884048 Published: 2026-10-01 Ingested: 2026-10-18 09:15 AM International journal of molecular sciences
AI -
Standard 57.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 57.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
AI -
Standard 57.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 57.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
Multiple Basal Cell Carcinomas in an Adolescent with an MLPA-Detected PTCH1-Region Deletion and a Gorlin-Goltz Phenotype.
PMID 42877390 Published: 2026-10-14 Ingested: 2026-10-17 09:15 AM Balkan journal of medical genetics : BJMG
AI -
Standard 57.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 57.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
AI -
Standard 57.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 57.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
International patterns and incidence trends of lung cancer in adolescent and young adults by histological subtype and sex.
PMID 42873587 Published: 2026-10-14 Ingested: 2026-10-16 09:15 AM Annals of the American Thoracic Society
AI -
Standard 57.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 57.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
Palliative Care Education for Spiritual Care Providers and Faith Leaders: A Global Integrative Review.
PMID 42868509 Published: 2026-10-13 Ingested: 2026-10-15 09:15 AM The American journal of hospice & palliative care
AI -
Standard 57.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 57.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
AI -
Standard 57.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 57.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
AI -
Standard 57.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 57.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

Previous
Page 2235 of 3336
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic